Skip to content

Clinical trials

Completed Lung Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Japan Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20041
20051
20061
20091
20104
20123
20134
20155
20161
20172
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Japan Multinational Trial Organization3
Shiga University3
AstraZeneca2
Bristol-Myers Squibb2
Gunma University2
Gustave Roussy, Cancer Campus, Grand Paris2
Japan Clinical Oncology Group2
Pfizer2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms36
Carcinoma, Non-Small-Cell Lung20
Adenocarcinoma of Lung8
Neoplasms5
Kidney Neoplasms3
Neoplasm Metastasis3
Small Cell Lung Carcinoma3
Stomach Neoplasms3
Breast Neoplasms2
Esophageal Neoplasms2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.